Class information for:
Level 1: CYP17//ANDROGEN RECEPTOR GENE//CAG REPEAT POLYMORPHISM

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
11354 921 38.7 89%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
645 12871 MAMMOGRAPHIC DENSITY//BREAST DENSITY//CANCER CAUSES & CONTROL

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CYP17 Author keyword 15 26% 5% 50
2 ANDROGEN RECEPTOR GENE Author keyword 14 31% 4% 37
3 CAG REPEAT POLYMORPHISM Author keyword 12 63% 1% 12
4 CAG REPEAT Author keyword 10 20% 5% 43
5 GGN REPEAT Author keyword 9 83% 1% 5
6 CAG POLYMORPHISM Author keyword 9 67% 1% 8
7 CYP19 Author keyword 9 20% 4% 39
8 CYP19A1 Author keyword 9 32% 2% 22
9 SRD5A2 Author keyword 8 37% 2% 17
10 CYP17 GENE Author keyword 6 48% 1% 10

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CYP17 15 26% 5% 50 Search CYP17 Search CYP17
2 ANDROGEN RECEPTOR GENE 14 31% 4% 37 Search ANDROGEN+RECEPTOR+GENE Search ANDROGEN+RECEPTOR+GENE
3 CAG REPEAT POLYMORPHISM 12 63% 1% 12 Search CAG+REPEAT+POLYMORPHISM Search CAG+REPEAT+POLYMORPHISM
4 CAG REPEAT 10 20% 5% 43 Search CAG+REPEAT Search CAG+REPEAT
5 GGN REPEAT 9 83% 1% 5 Search GGN+REPEAT Search GGN+REPEAT
6 CAG POLYMORPHISM 9 67% 1% 8 Search CAG+POLYMORPHISM Search CAG+POLYMORPHISM
7 CYP19 9 20% 4% 39 Search CYP19 Search CYP19
8 CYP19A1 9 32% 2% 22 Search CYP19A1 Search CYP19A1
9 SRD5A2 8 37% 2% 17 Search SRD5A2 Search SRD5A2
10 CYP17 GENE 6 48% 1% 10 Search CYP17+GENE Search CYP17+GENE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 IMPAIRED SPERM PRODUCTION 54 76% 4% 38
2 METABOLISM GENE CYP17 45 90% 2% 19
3 SRD5A2 33 83% 2% 19
4 5 ALPHA REDUCTASE TYPE II 23 74% 2% 17
5 MISSENSE SUBSTITUTION 21 71% 2% 17
6 SRD5A2 GENE 18 47% 3% 28
7 CYP17 POLYMORPHISM 15 82% 1% 9
8 MSPA1 POLYMORPHISM 15 88% 1% 7
9 POLYMORPHIC CAG 15 88% 1% 7
10 POLYGLUTAMINE TRACTS 14 51% 2% 19

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy 2015 1 113 30%
Association of the CAG repeat polymorphisms in androgen receptor gene with polycystic ovary syndrome: A systemic review and meta-analysis 2013 8 43 65%
Prostate cancer epidemiology 2006 188 218 23%
Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: A HuGE review 2007 67 81 44%
Negative association between androgen receptor gene CAG repeat polymorphism and polycystic ovary syndrome? A systematic review and meta-analysis 2012 7 36 58%
Polymorphisms in Genes Involved in Androgen Pathways as Risk Factors for Prostate Cancer 2009 19 47 62%
Phenotypic heterogeneity of mutations in androgen receptor gene 2007 49 272 45%
Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes 2013 6 226 42%
Steroid 5-alpha-Reductase Type 2 (SRD5a2) Gene Polymorphisms and Risk of Prostate Cancer: A HuGE Review 2010 17 71 54%
CYP17 gene polymorphisms: Prevalence and associations with hormone levels and related factors. A HuGE review 2004 63 73 53%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 MOL REPROD MED UNIT 5 60% 0.7% 6
2 JOINT EXPT ONCOL PROGRAMME 2 32% 0.7% 6
3 AFFILIATED ZHEJIANG CANC HOSP 2 67% 0.2% 2
4 ZHONGSHAN HOSP CANC 2 67% 0.2% 2
5 PLUNKETT CHAIR MOL BIOL MED 2 36% 0.4% 4
6 ANDROL PATHOPHYSIOL REPROD ENDOCRINE DIAG UNIT 1 38% 0.3% 3
7 BONE SAHLGRENSKA 1 50% 0.2% 2
8 CA S ALLIANCE MED CORP 1 50% 0.2% 2
9 CANC UNITED KINGDOM EPIDEMIOL UNIT 1 100% 0.2% 2
10 CLIN SCI MOL GENET REPROD MED 1 100% 0.2% 2

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000207117 ESTROGEN RECEPTOR ALPHA GENE ESR1//ESTROGEN RECEPTOR POLYMORPHISMS//ESTROGEN RECEPTOR 1
2 0.0000189234 SPINAL AND BULBAR MUSCULAR ATROPHY//KENNEDYS DISEASE//KENNEDY DISEASE
3 0.0000148639 ANDROGEN RECEPTOR//ANDROGEN INSENSITIVITY SYNDROME//ANDROGEN INSENSITIVITY
4 0.0000143458 MOLECULAR APOCRINE//DAME ROMA MITCHELL CANC S//ESTROGEN RECEPTOR NEGATIVE
5 0.0000138298 RNASEL//HEREDITARY PROSTATE CANCER//8Q24
6 0.0000082160 CYP1B1//CYP2S1//CYTOCHROME P4501B1
7 0.0000073752 JAMAICA CANC REGISTRY//PROSTATE CANC PROJECT//AFRICAN AMERICAN MEN
8 0.0000066894 ATLAS PROJECT//AUXIN A//AUXIN B
9 0.0000064395 STEROID SULFATASE//ESTRONE SULFATASE//AROMATASE
10 0.0000061447 5 ALPHA REDUCTASE//FINASTERIDE//BIOL SYST ANIM PROD